N-substituted piperazinopyridylsteroid derivatives as abiraterone analogues inhibit growth and induce pro-apoptosis in human hormone-independent prostate cancer cell lines.
about
An overview of molecular hybrids in drug discovery.The unidirectional hypoxia-activated prodrug OCT1002 inhibits growth and vascular development in castrate-resistant prostate tumors.Illuminating cytochrome P450 binding: Ru(ii)-caged inhibitors of CYP17A1.Ru(ii) polypyridyl complexes as photocages for bioactive compounds containing nitriles and aromatic heterocycles.
P2860
N-substituted piperazinopyridylsteroid derivatives as abiraterone analogues inhibit growth and induce pro-apoptosis in human hormone-independent prostate cancer cell lines.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
N-substituted piperazinopyridy ...... nt prostate cancer cell lines.
@en
N-substituted piperazinopyridy ...... nt prostate cancer cell lines.
@nl
type
label
N-substituted piperazinopyridy ...... nt prostate cancer cell lines.
@en
N-substituted piperazinopyridy ...... nt prostate cancer cell lines.
@nl
prefLabel
N-substituted piperazinopyridy ...... nt prostate cancer cell lines.
@en
N-substituted piperazinopyridy ...... nt prostate cancer cell lines.
@nl
P2093
P2860
P50
P356
P1476
N-substituted piperazinopyridy ...... ent prostate cancer cell lines
@en
P2093
Dominique Brossard
Laïla El Kihel
Miriam Sgobba
Mohamed Khalid
Philippe Galera
Rémi Legay
Safa Moslemi
Sylvain Rault
Ying Zhang
P2860
P304
P356
10.1111/CBDD.12195
P577
2013-11-01T00:00:00Z